Pathological response after neoadjuvant bevacizumab- or cetuximab-based chemotherapy in resected colorectal cancer liver metastases
暂无分享,去创建一个
V. Mazzaferro | R. Miceli | F. Perrone | M. Milione | F. Braud | F. Pietrantonio | E. Tamborini | P. Biondani | C. Maggi | G. Fanetti | J. Coppa | C. Cotsoglou | M. Bartolomeo | F. Melotti | C. Muscarà